A Pilot Study of Leukocytapheresis Efficacy With 1.5 Liter Blood Processing Volume in Patients With Ulcerative Colitis-Reference-Cited by-同舟云学术

A Pilot Study of Leukocytapheresis Efficacy With 1.5 Liter Blood Processing Volume in Patients With Ulcerative Colitis

Published:2008-10-02 Issue:5 Volume:12 Page:368-373
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:

Author:

Shimada Masaaki,Iwase Hiroaki,Tsuzuki Tomoyuki,Hirashima Noboru,Kobayashi Kyoko,Hibino Yusuke,Watanabe Hisanori,Ryuge Nobumitsu,Ando Takafumi,Goto Hidemi,Yagi Yuhki,Tsujikawa Tomoyuki,Andoh Akira

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1744-9987.2008.00611.x/fullpdf

Reference17 articles.

1. Inflammatory bowel disease;Podolsky;N Engl J Med,2002

2. Novel pathophysiological concepts of inflammatory bowel disease;Hibi;J Gastroenterol,2006

3. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment;Sawada;Am J Gastroenterol,2005

4. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column;Sawada;Curr Pharm Des,2003

5. Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon;Sawada;Dig Dis Sci,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apheresis in Inflammatory Bowel Disease: Current Evidence;Crohn’s Disease Recent Advances;2021-10-20

2. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease;World Journal of Gastroenterology;2014

3. Valutazione economica del sistema di aferesi per la rimozione di granulociti e macrofagi (Adacolumn®) rispetto a biologico nel trattamento della colite ulcerosa moderata-severa in pazienti steroido-dipendenti o resistenti in Italia;Giornale Italiano di Health Technology Assessment;2013-08-30

4. Therapeutic landscape for ulcerative colitis: where is the Adacolumn® system and where should it be?;Clinical and Experimental Gastroenterology;2013-01

5. Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with cellsorba in patients with active ulcerative colitis;Journal of Clinical Apheresis;2011-11-14